VolitionRX Ltd Stock OTC Bulletin Board
Stocks
VNRX
US9286611077
Biotechnology & Medical Research
| Market Cap | 8.33M 7.32M 6.8M 6.24M 11.73M 802M 11.91M 80.8M 31.57M 394M 31.27M 30.6M 1.36B | P/E 2026 * |
-0.45x | P/E 2027 * | -0.72x |
|---|---|---|---|---|---|
| Enterprise Value | 8.33M 7.32M 6.8M 6.24M 11.73M 802M 11.91M 80.8M 31.57M 394M 31.27M 30.6M 1.36B | EV / Sales 2026 * |
3.36x | EV / Sales 2027 * | 1.45x |
| Free-Float |
91.38% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: VolitionRX Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 55 | 06/10/2011 |
Terig Hughes
DFI | Director of Finance/CFO | 56 | 01/02/2021 |
Andrew Retter
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Timothy Still
CHM | Chairman | 61 | 06/11/2024 |
Cameron Reynolds
BRD | Director/Board Member | 55 | 06/10/2011 |
Ethel Rubin
BRD | Director/Board Member | 57 | 30/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.33M | |
| -2.19% | -4.26% | +124.20% | +98.42% | 4.52B | |
| -0.18% | -2.84% | +107.16% | +183.69% | 3.56B | |
| -2.73% | -0.20% | +59.42% | -29.62% | 2.23B | |
| -0.90% | +1.56% | -30.49% | -37.69% | 2.07B | |
| -1.25% | -6.52% | +190.38% | +237.33% | 1.92B | |
| -4.11% | -6.63% | +151.30% | -42.22% | 997M | |
| -0.54% | -4.03% | -9.12% | +32.37% | 855M | |
| -3.59% | -6.57% | -42.53% | -18.46% | 479M | |
| +4.02% | -5.71% | -0.26% | - | 457M | |
| Average | -1.15% | -1.53% | +61.12% | +52.98% | 1.9B | |
| Weighted average by Cap. | -1.48% | -2.61% | +87.80% | +83.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.48M 2.18M 2.02M 1.86M 3.49M 239M 3.54M 24.03M 9.39M 117M 9.3M 9.1M 406M | 5.73M 5.04M 4.68M 4.3M 8.07M 552M 8.2M 55.61M 21.73M 271M 21.52M 21.06M 939M |
| Net income | -22.2M -19.5M -18.14M -16.64M -31.27M -2.14B -31.75M -215M -84.14M -1.05B -83.35M -81.55M -3.63B | -19.62M -17.23M -16.02M -14.7M -27.63M -1.89B -28.06M -190M -74.34M -929M -73.65M -72.06M -3.21B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
